Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
Alzheimer'S Research & Therapy|December 9, 2014
Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?Emilio Merlo Pich, Andreas Jeromin, Giovanni B Frisoni, et al.NPJ Parkinson'S Disease|October 2, 2023
Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's diseaseJessica Grigoletto, Fabiana Miraglia, Laura Benvenuti, et al.Experimental and Clinical Psychopharmacology|December 9, 2009
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinenceAmy C Janes, Blaise deB Frederick, Sarah Richardt, et al.Molecular Pharmacology|April 2, 2013
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signalingGinetta Collo, Federica Bono, Laura Cavalleri, et al.Frontiers in Aging Neuroscience|April 29, 2021
Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and CaregiversThanos G Stavropoulos, Ioulietta Lazarou, Ana Diaz, et al.Journal of Psychiatry & Neuroscience : JPN|January 7, 2009
Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorderTomas Furmark, Susanne Henningsson, Lieuwe Appel, et al.Appetite|March 27, 2012
Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eatersChris M Dodds, Barry O'Neill, John Beaver, et al.Neuroimage|August 30, 2011
Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorderDavid Meunier, Karen D Ersche, Kevin J Craig, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 20, 2016
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorderAndreas Frick, Fredrik Åhs, Lieuwe Appel, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 26, 2016
The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving EffectsMelanie L Schwandt, Carlos R Cortes, Laura E Kwako, et al.Pageof 10